Emine Vezir
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Emine Vezir has a total of 255 co-authors. Here are the top co-authors by number of shared publications:
- Dilek Azkur
Pediatric Immunology and Allergy Department, Kırıkkale University Hospital, Kırıkkale, Turkey
6 shared publications - Ayşenur Kaya
Department of Pediatric Allergy and Immunology, Ankara Children's Hematology Oncology Training and Research Hospital, Ankara, Turkey
5 shared publications - Can Naci Kocabaş
Division of Pediatric Allergy and Immunology, Department of Children's Health and Diseases, Faculty of Medicine, Mugla Sitki Kocman University, Mugla, Turkey
5 shared publications Fatma Demirel
Department of Pediatric Endocrinology, Ankara Children's Hematology Oncology Training and Research Hospital, Ankara, Turkey
5 shared publicationsA. Shiozawa
4 shared publicationsA. Wesley Burks
4 shared publications
Latest Publications
- 19 October 2026
- Published by Springer Nature in Clinical Reviews in Allergy & Immunology
- Vol. 69 (1) , 86
Immune Checkpoint Dysfunction Remodels Adaptive Immune Receptor Repertoires in CTLA-4 Insufficiency and LRBA Deficiency
- 19 October 2026
- Published by Springer Nature in Clinical Reviews in Allergy & Immunology
- Vol. 69 (1) , 86
Immune Checkpoint Dysfunction Remodels Adaptive Immune Receptor Repertoires in CTLA-4 Insufficiency and LRBA Deficiency
- 30 June 2026
- Published by Wiley in Pediatric Pulmonology
- Vol. 61 (7) , e71721
Long‐Term Effect Of COVID‐19 on Children's Lung Function: A Prospective Longitudinal Study
Introduction‐Aim: The study evaluates the long‐term effect of COVID‐19 on lung function in children, considering symptoms, physical examination findings, radiologic and laboratory evaluations during the acute infection period (AIP). Material and Methods: This prospective, longitudinal, multicenter study involved 270 patients with confirmed SARS‐CoV‐2 infection. Patients underwent pulmonary function tests (PFTs) (spirometry, diffusion capacity of the lung for carbon monoxide (DLCO), and plethysmography) at the 3rd and 6th months of follow‐up. Clinical characteristics, radiological, and laboratory findings during AIP were analyzed to establish the relationship with PFT parameters on long‐term follow‐up. Results: The mean age was 12.97 ± 3.43 years (6–18 years), and 141(52.2%) were girls. Most patients had mild disease, while 193 patients were classified as having pneumonia. Overall mean PFT parameters were normal at the 3rd and 6th months, and FEV 1 %, FVC%, and DLCOadj% showed statistically significant longitudinal changes. Abnormal DLCOadj was observed in patients with COVID‐19 pneumonia at the 6th month when compared with the non‐pneumonia group ( p = 0.046). At the 3rd month follow‐up, comorbidities were independently associated with abnormal FEV 1 (OR 6.30, 95% CI 2.61–15.17, p < 0.001) and abnormal FVC (OR 3.47, 95% CI 1.72–7.00, p < 0.001). Respiratory system related abnormal physical examination findings were also independently associated with abnormal FEV 1 (OR 3.04, 95% CI 1.13–8.21, p = 0.028). Dyspnea showed a borderline association with abnormal FVC (OR 2.11, 95% CI 0.98–4.54, p = 0.057). Pathologic chest radiography, interlobular septal thickening on thorax CT, ground‐glass opacity, fever, dyspnea, and respiratory system related abnormal physical examination findings during the AIP were associated with abnormal PFT parameters during follow‐up. Disease severity scores did not differ significantly between children with normal and abnormal. Conclusions: Most children had preserved mean pulmonary function during follow‐up after SARS‐CoV‐2 infection. However, children with COVID‐19 pneumonia, comorbidities, and respiratory system related abnormal physical examination findings during the AIP may be at increased risk for persistent functional abnormalities. Follow‐up assessment in higher‐risk children should include spirometry, and DLCO measurement should be considered when feasible.
- 30 June 2026
- Published by Wiley in Pediatric Pulmonology
- Vol. 61 (7) , e71721
Long‐Term Effect Of COVID‐19 on Children's Lung Function: A Prospective Longitudinal Study
Introduction‐Aim: The study evaluates the long‐term effect of COVID‐19 on lung function in children, considering symptoms, physical examination findings, radiologic and laboratory evaluations during the acute infection period (AIP). Material and Methods: This prospective, longitudinal, multicenter study involved 270 patients with confirmed SARS‐CoV‐2 infection. Patients underwent pulmonary function tests (PFTs) (spirometry, diffusion capacity of the lung for carbon monoxide (DLCO), and plethysmography) at the 3rd and 6th months of follow‐up. Clinical characteristics, radiological, and laboratory findings during AIP were analyzed to establish the relationship with PFT parameters on long‐term follow‐up. Results: The mean age was 12.97 ± 3.43 years (6–18 years), and 141(52.2%) were girls. Most patients had mild disease, while 193 patients were classified as having pneumonia. Overall mean PFT parameters were normal at the 3rd and 6th months, and FEV 1 %, FVC%, and DLCOadj% showed statistically significant longitudinal changes. Abnormal DLCOadj was observed in patients with COVID‐19 pneumonia at the 6th month when compared with the non‐pneumonia group ( p = 0.046). At the 3rd month follow‐up, comorbidities were independently associated with abnormal FEV 1 (OR 6.30, 95% CI 2.61–15.17, p < 0.001) and abnormal FVC (OR 3.47, 95% CI 1.72–7.00, p < 0.001). Respiratory system related abnormal physical examination findings were also independently associated with abnormal FEV 1 (OR 3.04, 95% CI 1.13–8.21, p = 0.028). Dyspnea showed a borderline association with abnormal FVC (OR 2.11, 95% CI 0.98–4.54, p = 0.057). Pathologic chest radiography, interlobular septal thickening on thorax CT, ground‐glass opacity, fever, dyspnea, and respiratory system related abnormal physical examination findings during the AIP were associated with abnormal PFT parameters during follow‐up. Disease severity scores did not differ significantly between children with normal and abnormal. Conclusions: Most children had preserved mean pulmonary function during follow‐up after SARS‐CoV‐2 infection. However, children with COVID‐19 pneumonia, comorbidities, and respiratory system related abnormal physical examination findings during the AIP may be at increased risk for persistent functional abnormalities. Follow‐up assessment in higher‐risk children should include spirometry, and DLCO measurement should be considered when feasible.
- 5 May 2026
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 37 (5) , e70345
One day versus five day drug provocation tests in mild delayed cutaneous beta lactam reactions in children: Negative predictive value and real‐life reuse outcomes
Background: Although drug provocation test (DPT) is the gold standard for diagnosing beta‐lactam hypersensitivity (BLHS), its optimal duration in mild non‐immediate cutaneous reactions remains uncertain. We compared the outcomes and negative predictive values (NPVs) of one‐day versus five‐day DPT protocols in children with suspected mild non‐immediate cutaneous BLHS. Methods: We retrospectively reviewed patients (p = .768). Five underwent re‐provocation, with one confirmed positive. Final NPVs were 93.1% for the one‐day protocol and 98% for the five‐day protocol ( p = .333). Conclusion: In this period‐based retrospective cohort of selected low‐risk children with mild non‐immediate cutaneous beta‐lactam allergy, one‐day and five‐day DPT protocols yielded comparable NPVs. A single‐day protocol appears feasible for appropriately selected patients, although prospective studies are warranted.
- 5 May 2026
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 37 (5) , e70345
One day versus five day drug provocation tests in mild delayed cutaneous beta lactam reactions in children: Negative predictive value and real‐life reuse outcomes
Background: Although drug provocation test (DPT) is the gold standard for diagnosing beta‐lactam hypersensitivity (BLHS), its optimal duration in mild non‐immediate cutaneous reactions remains uncertain. We compared the outcomes and negative predictive values (NPVs) of one‐day versus five‐day DPT protocols in children with suspected mild non‐immediate cutaneous BLHS. Methods: We retrospectively reviewed patients (p = .768). Five underwent re‐provocation, with one confirmed positive. Final NPVs were 93.1% for the one‐day protocol and 98% for the five‐day protocol ( p = .333). Conclusion: In this period‐based retrospective cohort of selected low‐risk children with mild non‐immediate cutaneous beta‐lactam allergy, one‐day and five‐day DPT protocols yielded comparable NPVs. A single‐day protocol appears feasible for appropriately selected patients, although prospective studies are warranted.
- Open Access
- 1 November 2025
- Published by Codon Publications in Allergologia et Immunopathologia
- Vol. 53 (6) , 46-54
Evaluation of clinical and demographic characteristics in children with aeroallergen sensitization: A study based on skin prick test results
Objective: This study aimed to evaluate the demographic and clinical features of pediatric aeroallergen sensitization and seasonal symptom patterns, focusing on pollen. Materials and methods: This retrospective single-center study included children aged 1–18 years who underwent standardized skin prick testing (SPT) between January 2020 and July 2021. Patients with chronic or immunological disorders other than asthma, allergic rhinitis (AR), and atopic dermatitis (AD) were excluded. Clinical and laboratory data, including symptom profiles, family atopy history, eosinophil counts, and total IgE, were extracted from records. Aeroallergen panels included pollens, house dust mites, molds, and animal dander. Comparisons were performed between monosensitized and polysensitized patients, and between those sensitized to pollen versus house dust mites. Results: Of 2247 children tested, 2017 were eligible, and 500 (24.7%) with clinically relevant sensitization were analyzed (57% male; median age: 12 years, IQR: 8–15). Pollen was the most frequent sensitizer (78.6%), followed by house dust mites (36.6%). Within pollens, Poaceae predominated (98.1%), with Secale as the leading species (88.4%). Seasonal peaks of symptoms in pollen-sensitized patients occurred in May (31.8%), April (29.6%), and June (27%). Polysensitization was observed in 38.8%. AR was the most common diagnosis (83.2%), while asthma and AD were present in 36.4% and 34.0%, respectively. Pollen sensitization was significantly associated with AR (88% vs. 63%, p < 0.01) and sneezing (38% vs. 16%, p < 0.01), whereas house dust mite sensitization was more often linked with skin rashes (25.5% vs. 13%, p = 0.008). Patients with eosinophilia were younger, predominantly male, and more frequently diagnosed with AR (p < 0.001). Conclusions: Pollen, particularly from the Poaceae family, was the predominant aeroallergen, and symptom timing matched seasonal pollen trends. Inclusion of region-specific pollens such as Secale in SPT panels is crucial for accurate sensitization detection and for guiding localized public health strategies.
- 1 November 2025
- Published by Codon Publications in Allergologia et Immunopathologia
- Vol. 53 (6) , 46-54
Open AccessEvaluation of clinical and demographic characteristics in children with aeroallergen sensitization: A study based on skin prick test results
Objective: This study aimed to evaluate the demographic and clinical features of pediatric aeroallergen sensitization and seasonal symptom patterns, focusing on pollen. Materials and methods: This retrospective single-center study included children aged 1–18 years who underwent standardized skin prick testing (SPT) between January 2020 and July 2021. Patients with chronic or immunological disorders other than asthma, allergic rhinitis (AR), and atopic dermatitis (AD) were excluded. Clinical and laboratory data, including symptom profiles, family atopy history, eosinophil counts, and total IgE, were extracted from records. Aeroallergen panels included pollens, house dust mites, molds, and animal dander. Comparisons were performed between monosensitized and polysensitized patients, and between those sensitized to pollen versus house dust mites. Results: Of 2247 children tested, 2017 were eligible, and 500 (24.7%) with clinically relevant sensitization were analyzed (57% male; median age: 12 years, IQR: 8–15). Pollen was the most frequent sensitizer (78.6%), followed by house dust mites (36.6%). Within pollens, Poaceae predominated (98.1%), with Secale as the leading species (88.4%). Seasonal peaks of symptoms in pollen-sensitized patients occurred in May (31.8%), April (29.6%), and June (27%). Polysensitization was observed in 38.8%. AR was the most common diagnosis (83.2%), while asthma and AD were present in 36.4% and 34.0%, respectively. Pollen sensitization was significantly associated with AR (88% vs. 63%, p < 0.01) and sneezing (38% vs. 16%, p < 0.01), whereas house dust mite sensitization was more often linked with skin rashes (25.5% vs. 13%, p = 0.008). Patients with eosinophilia were younger, predominantly male, and more frequently diagnosed with AR (p < 0.001). Conclusions: Pollen, particularly from the Poaceae family, was the predominant aeroallergen, and symptom timing matched seasonal pollen trends. Inclusion of region-specific pollens such as Secale in SPT panels is crucial for accurate sensitization detection and for guiding localized public health strategies.
- Open Access
- 28 April 2025
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 184 (5) , 1
Correction to: Evaluation of drug-related anaphylaxis in children: multi-center study
- 28 April 2025
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 184 (5) , 1
Open AccessCorrection to: Evaluation of drug-related anaphylaxis in children: multi-center study
- 7 March 2025
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 184 (3) , 1-11
Evaluation of drug-related anaphylaxis in children: multi-center study
The aim of the study is to elucidate demographic characteristics, risk factors, clinical presentations, causative agents, and management approaches pertaining to drug-related anaphylaxis in the paediatric population. This study is a multicenter retrospective study that included paediatric patients aged between 1 month and 18 years, who were admitted to the Pediatric Allergy and Immunology outpatient clinics of 11 participating centres with a presumptive diagnosis of drug-induced anaphylaxis, that fulfilled the standardised criteria for anaphylaxis, between January 2017 and December 2022. A total of 293 anaphylactic episodes presented among 265 patients, of which 48.1% (n 141) were female, were included. The median age of patients during the index episode was 107 months (IQR 56.5–161.5). Anaphylaxis occurred most frequently within hospital settings (62.1%, n 182) compared to home environments (34.1%, n 100). The administration were peroral in 40.3% (n 118), parenteral in 59.7% (n 175) of the cases. While antibiotics (56.7%), non-steroidal anti-inflammatory drugs (25.7%), and chemotherapeutics (3.4%) were the most commonly suspected drug groups, the cephalosporin group, and especially ceftriaxone (27.5% [n 80]) were the leading culprits among antibiotics. The anaphylaxis severity was severe in 39.6% (n 116), and moderate in 54.9% (n 161) of episodes. A biphasic reaction occurred in five patients. Only 72% (n 213) of patients were given adrenaline treatment. There were no fatalities. Diagnostic tests (n 64), including skin prick, intradermal, and drug provocation tests, which were performed between 1 and 120 months after the index reaction, yielded positive results in 23.4% (n 15), 17.2% (n 11), and 20.3% (n 13) of cases respectively, giving a total confirmation of 39 patients. Four patients underwent suspected drug desensitisation protocols. There were no fatalities. Conclusions: Antibiotics, particularly ceftriaxone, were the most commonly implicated agents in paediatric drug-induced anaphylaxis. Non-steroidal anti-inflammatory drugs, particularly ibuprofen, constituted the second most frequently implicated drug group. Paediatric patients experiencing drug-related anaphylaxis warrant algorithmic evaluation to ensure accurate diagnosis, prevent recurrence, and identify safe alternative treatments. What is Known: • Antibiotics, particularly ceftriaxone were the most frequently implicated culprit drugs, followed by NSAIDs, with ibuprofen being the most common within this group. What is New: • To the best of our knowledge, this is the largest multicenter paediatric drug-related anaphylaxis study, involving a large number of patients who evaluated by paediatric allergist. • We propose paediatric patients who experience drug induced anaphylaxis should undergo evaluation at specialized centres, to ensure accurate diagnosis, to prevent recurrence and identify safe alternative treatments.
- 7 March 2025
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 184 (3) , 1-11
Evaluation of drug-related anaphylaxis in children: multi-center study
The aim of the study is to elucidate demographic characteristics, risk factors, clinical presentations, causative agents, and management approaches pertaining to drug-related anaphylaxis in the paediatric population. This study is a multicenter retrospective study that included paediatric patients aged between 1 month and 18 years, who were admitted to the Pediatric Allergy and Immunology outpatient clinics of 11 participating centres with a presumptive diagnosis of drug-induced anaphylaxis, that fulfilled the standardised criteria for anaphylaxis, between January 2017 and December 2022. A total of 293 anaphylactic episodes presented among 265 patients, of which 48.1% (n 141) were female, were included. The median age of patients during the index episode was 107 months (IQR 56.5–161.5). Anaphylaxis occurred most frequently within hospital settings (62.1%, n 182) compared to home environments (34.1%, n 100). The administration were peroral in 40.3% (n 118), parenteral in 59.7% (n 175) of the cases. While antibiotics (56.7%), non-steroidal anti-inflammatory drugs (25.7%), and chemotherapeutics (3.4%) were the most commonly suspected drug groups, the cephalosporin group, and especially ceftriaxone (27.5% [n 80]) were the leading culprits among antibiotics. The anaphylaxis severity was severe in 39.6% (n 116), and moderate in 54.9% (n 161) of episodes. A biphasic reaction occurred in five patients. Only 72% (n 213) of patients were given adrenaline treatment. There were no fatalities. Diagnostic tests (n 64), including skin prick, intradermal, and drug provocation tests, which were performed between 1 and 120 months after the index reaction, yielded positive results in 23.4% (n 15), 17.2% (n 11), and 20.3% (n 13) of cases respectively, giving a total confirmation of 39 patients. Four patients underwent suspected drug desensitisation protocols. There were no fatalities. Conclusions: Antibiotics, particularly ceftriaxone, were the most commonly implicated agents in paediatric drug-induced anaphylaxis. Non-steroidal anti-inflammatory drugs, particularly ibuprofen, constituted the second most frequently implicated drug group. Paediatric patients experiencing drug-related anaphylaxis warrant algorithmic evaluation to ensure accurate diagnosis, prevent recurrence, and identify safe alternative treatments. What is Known: • Antibiotics, particularly ceftriaxone were the most frequently implicated culprit drugs, followed by NSAIDs, with ibuprofen being the most common within this group. What is New: • To the best of our knowledge, this is the largest multicenter paediatric drug-related anaphylaxis study, involving a large number of patients who evaluated by paediatric allergist. • We propose paediatric patients who experience drug induced anaphylaxis should undergo evaluation at specialized centres, to ensure accurate diagnosis, to prevent recurrence and identify safe alternative treatments.
- Open Access
- 20 August 2024
- Published by Kirikkale Universitesi Tip Fakultesi Dergisi in Kırıkkale Üniversitesi Tıp Fakültesi Dergisi
- Vol. 26 (2) , 194-200
EVALUATION OF FOOD SENSITIVITY IN CHILDREN WITH ATOPIC DERMATITIS
Objective: Atopic dermatitis is considered an important risk factor for the development of food allergies. This retrospective study aimed to evaluate food sensitivity in pediatric patients with atopic dermatitis based on skin prick tests. Material and Methods: The study included children diagnosed with atopic dermatitis who underwent skin prick tests with food allergens at our hospital’s Pediatric Allergy Clinic between January 1, 2023 and January 31, 2024. Demographic data, atopic dermatitis onset age, severity, treatments, and co-existing atopic diseases (asthma, allergic rhinitis) were collected from medical records. Skin prick test results were evaluated retrospectively. Results: The study comprised 229 patients, predominantly male (64.2%) with a median age of 7 months (IQR:5-14). The median age at atopic dermatitis onset was 3 (IQR:2-6) months. Co-existing allergic diseases were present in 12 (5.2%) patients. Based on SCORing Atopic Dermatitis (SCORAD), atopic dermatitis severity was mild in 61.1%, moderate in 29.3%, and severe in 9.6% of patients. Food allergen sensitization was observed in 73 (31.9%) patients, predominantly to hen's egg (28.4%). Multiple food sensitivities occurred in 10% of patients (n=23). Patients with food sensitivityshowed earlier atopic dermatitis onset, higher total IgE and eosinophil counts, and more frequent moderate-severe atopic dermatitis (p500/ mm3 as risk factors for sensitization. Conclusion: Approximately one-third of pediatric atopic dermatitis patients exhibited sensitivity to at least one food allergen, most commonly hen’s egg. Early atopic dermatitis onset, elevated eosinophils, and moderate-severe atopic dermatitis pose a higher risk for sensitization. Hence, mitigating unnecessary elimination diets and prompt referral of these patients to pediatric allergy clinics is crucial.
- 20 August 2024
- Published by Kirikkale Universitesi Tip Fakultesi Dergisi in Kırıkkale Üniversitesi Tıp Fakültesi Dergisi
- Vol. 26 (2) , 194-200
Open AccessEVALUATION OF FOOD SENSITIVITY IN CHILDREN WITH ATOPIC DERMATITIS
Objective: Atopic dermatitis is considered an important risk factor for the development of food allergies. This retrospective study aimed to evaluate food sensitivity in pediatric patients with atopic dermatitis based on skin prick tests. Material and Methods: The study included children diagnosed with atopic dermatitis who underwent skin prick tests with food allergens at our hospital’s Pediatric Allergy Clinic between January 1, 2023 and January 31, 2024. Demographic data, atopic dermatitis onset age, severity, treatments, and co-existing atopic diseases (asthma, allergic rhinitis) were collected from medical records. Skin prick test results were evaluated retrospectively. Results: The study comprised 229 patients, predominantly male (64.2%) with a median age of 7 months (IQR:5-14). The median age at atopic dermatitis onset was 3 (IQR:2-6) months. Co-existing allergic diseases were present in 12 (5.2%) patients. Based on SCORing Atopic Dermatitis (SCORAD), atopic dermatitis severity was mild in 61.1%, moderate in 29.3%, and severe in 9.6% of patients. Food allergen sensitization was observed in 73 (31.9%) patients, predominantly to hen's egg (28.4%). Multiple food sensitivities occurred in 10% of patients (n=23). Patients with food sensitivityshowed earlier atopic dermatitis onset, higher total IgE and eosinophil counts, and more frequent moderate-severe atopic dermatitis (p500/ mm3 as risk factors for sensitization. Conclusion: Approximately one-third of pediatric atopic dermatitis patients exhibited sensitivity to at least one food allergen, most commonly hen’s egg. Early atopic dermatitis onset, elevated eosinophils, and moderate-severe atopic dermatitis pose a higher risk for sensitization. Hence, mitigating unnecessary elimination diets and prompt referral of these patients to pediatric allergy clinics is crucial.
- Open Access
- 22 July 2024
- Published by Ankara Bilkent City Hospital in Turkish Journal of Pediatric Disease
- Vol. 18 (4) , 247-252
Characteristics of Drug Hypersensitivity Reactions in Children: A Retrospective Analysis in an Allergy Outpatient Clinic
Amaç: Çocuklardaki viral enfeksiyonlar gibi alerjik olmayan çeşitli reaksiyonlar ilaç hipersensitivite reaksiyonları (İHR)’yi taklit edebildiğinden, ilaca aşırı duyarlılık reaksiyonlarının (İADR) doğrulanması çok önemlidir. Bu çalışma, alerji polikliniğine İADR şüphesi ile başvuran çocukların özelliklerini değerlendirmeyi amaçlamaktadır.Gereç ve Yöntemler: Çalışmaya 1 Nisan 2023-31 Aralık 2023 tarihleri arasında hastanemiz çocuk alerji kliniği’ne İADR şüphesi ile başvuran çocuk hastalar dahil edildi. Hasta verileri retrospektif olarak analiz edildi. Hastanın demografik verileri, reaksiyon özellikleri, şüpheli ilaçlar, uygulanan tanısal testler (deri ve/veya provokasyon testleri) ve reaksiyonların nihai tanıları kaydedildi.Bulgular: Çalışmaya 140 hastanın 176 süpheli ilaç ile olan 163 reaksiyonu dahil edildi. Ortanca yaşları 7.7 yaş (Çeyrekler Arası Aralık [ÇAA]; 5.1-12) ve cinsiyet dağılımı eşitti. Hastaların %27.1’inde eşlik eden diğer atopik hastalık mevcuttu. Reaksiyon ortaya çıkış yaş ortancası 72 ay (ÇAA; 34.5-108 ay)’dı. Reaksiyonların %16’sı hastanede, %84’ü hastane dışında gelişirken; ilaçların % 84.7’si oral yolla alınmıştı. En sık sorumlu ajanlar antibiyotiklerdi (%75.5).Reaksiyonların %41.1’i (n=67) erken, %58.9’u (n= 96) ise geç tip reaksiyondu. En sık cilt semptomu (%97.5) görüldü. Reaksiyonların %75.5’inde (n=123) İHR ekarte edildi; %4.9’unda (n=8) ilaç alerjisi tanısal testler ile doğrulandı.Sonuç: Çocuklarda şüpheli İADR’nin ayrıntılı bir şekilde değerlendirilmesi önemlidir. Yüksek şüphe oranlarına rağmen tanı testleri ile doğrulama oranı düşüktü; bu da doğru yönetim için uzman kliniklere yönlendirmenin ve doğrulanmış tanıların gerekliliğini vurgulamaktadır.
- 22 July 2024
- Published by Ankara Bilkent City Hospital in Turkish Journal of Pediatric Disease
- Vol. 18 (4) , 247-252
Open AccessCharacteristics of Drug Hypersensitivity Reactions in Children: A Retrospective Analysis in an Allergy Outpatient Clinic
Amaç: Çocuklardaki viral enfeksiyonlar gibi alerjik olmayan çeşitli reaksiyonlar ilaç hipersensitivite reaksiyonları (İHR)’yi taklit edebildiğinden, ilaca aşırı duyarlılık reaksiyonlarının (İADR) doğrulanması çok önemlidir. Bu çalışma, alerji polikliniğine İADR şüphesi ile başvuran çocukların özelliklerini değerlendirmeyi amaçlamaktadır.Gereç ve Yöntemler: Çalışmaya 1 Nisan 2023-31 Aralık 2023 tarihleri arasında hastanemiz çocuk alerji kliniği’ne İADR şüphesi ile başvuran çocuk hastalar dahil edildi. Hasta verileri retrospektif olarak analiz edildi. Hastanın demografik verileri, reaksiyon özellikleri, şüpheli ilaçlar, uygulanan tanısal testler (deri ve/veya provokasyon testleri) ve reaksiyonların nihai tanıları kaydedildi.Bulgular: Çalışmaya 140 hastanın 176 süpheli ilaç ile olan 163 reaksiyonu dahil edildi. Ortanca yaşları 7.7 yaş (Çeyrekler Arası Aralık [ÇAA]; 5.1-12) ve cinsiyet dağılımı eşitti. Hastaların %27.1’inde eşlik eden diğer atopik hastalık mevcuttu. Reaksiyon ortaya çıkış yaş ortancası 72 ay (ÇAA; 34.5-108 ay)’dı. Reaksiyonların %16’sı hastanede, %84’ü hastane dışında gelişirken; ilaçların % 84.7’si oral yolla alınmıştı. En sık sorumlu ajanlar antibiyotiklerdi (%75.5).Reaksiyonların %41.1’i (n=67) erken, %58.9’u (n= 96) ise geç tip reaksiyondu. En sık cilt semptomu (%97.5) görüldü. Reaksiyonların %75.5’inde (n=123) İHR ekarte edildi; %4.9’unda (n=8) ilaç alerjisi tanısal testler ile doğrulandı.Sonuç: Çocuklarda şüpheli İADR’nin ayrıntılı bir şekilde değerlendirilmesi önemlidir. Yüksek şüphe oranlarına rağmen tanı testleri ile doğrulama oranı düşüktü; bu da doğru yönetim için uzman kliniklere yönlendirmenin ve doğrulanmış tanıların gerekliliğini vurgulamaktadır.
- Open Access
- 19 September 2022
- Published by Caleo in Turkish Archives of Pediatrics
- Vol. 58 (1) , 109-111
Hyperimmunoglobulin D Syndrome Presenting with Volvulus Due to Abdominal Fibro-Inflammatory Bands
Cite this article as: Kaan Aslan M, Cesur Ö, Özcan A, et al. Hyperimmunoglobulin D syndrome presenting with volvulus due to abdominal fibro-inflammatory bands. Turk Arch Pediatr. 2023;58(1):109-111.
- 19 September 2022
- Published by Caleo in Turkish Archives of Pediatrics
- Vol. 58 (1) , 109-111
Open AccessHyperimmunoglobulin D Syndrome Presenting with Volvulus Due to Abdominal Fibro-Inflammatory Bands
Cite this article as: Kaan Aslan M, Cesur Ö, Özcan A, et al. Hyperimmunoglobulin D syndrome presenting with volvulus due to abdominal fibro-inflammatory bands. Turk Arch Pediatr. 2023;58(1):109-111.